Effects of estradiol hemisuccinate and diethylstilbestrol diphosphate on the cardiovascular system in male rats were examined in vivo and in vitro.
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In Several effects of estrogen on the cardiovascular system have been reported in man and in animals. These results have been, however, quite controversial. Oral contraceptives or estrogen treatment raised blood pressure in man (Laragh et al., 1967; Saruta et al., 1970) and in rats (Saruta et al., 1975) , and accelerated the development of hypertension in rats with renovascular or DOCA-salt hypertension (Bunag et al., 1976) . Estrogen treatment, however, attenuated the development of hypertension in spontaneous hypertensive rats (Hoeg et tension in chickens (Stamler, 1954) . Estrogen was also reported to alter the vascular reactivity to vasoactive substances (Altura, 1975) . Besides its indirect effect via the renin-angiotensin system and sodium-water balance (Menard and Catt, 1973; Johnson vascular bed. Estrogen was initially reported to act on the peripheral vascular bed as a vasodilator substance (Reynolds and Foster, 1940; Ueland and Parer, 1966) , but this was not confirmed by a later study To examine the direct effect of estrogen upon the vascular bed, estrogen should be administered into the circulation. Diethylstilbestrol diphosphate (Honvan) is a commonly used estrogen which is usually administered intravenously.
In this experiment we examined the direct effect of diethylstilbestrol diphosphate, as well as that of estradiol hemisuccinate, on the vascular bed in vivo and in vitro, using conscious rats and isolated mesenteric arteries. 
Discussion
The results of the present study indicated that intravenously administered estradiol hemisuccinate or diethylstilbestrol diphosphate attenuated the pressor response to norepinephrine.
Furthermore, high doses of diethylstilbestrol lowered the blood pressure of conscious rats. Although the effect of estrogen on the heart should be considered (Lim et al., 1970 ; Stumpf et al., 1977) , the similar results we observed in the isolated vascular tissue strongly suggested that both estradiol and diethylstilbestrol also act directly on the vascular beds.
In contrast to our observations, Altura (1975) reported that pretreatment of male rats with estrogen resulted in an enhancement of the vasoconstrictor actions of catecholamines.
His observations, however, might not reflect the direct effect of estrogen on the vascular beds, because in his experiments estradiol was administered subcutaneously 18 to 24 hr before observation. Estrogen when it is administered in vivo changes hormonal balances, especially the renin-angiotensin system (Menard and Catt, 1973) and promotes sodium and water retention (Johnson et al., 1970) . These changes occur rather rapidly and might exert secondary effects upon vascular reactivity. In our study the vascular responses to norepinephrine were examined 12 minutes after the administration of estradiol or diethylstilbestrol into the circulation. This means, in addition to the observations in the mesenteric artery, that the inhibitory effect of estradiol or diethylstilbestrol on the pressor response to norepinephrine is attributable to its direct action on the vascular beds, not mediated by the change in hormonal or sodium balance.
In this study intravenous administration of 3 mg/kg of estradiol hemisuccinate did not change the blood pressure of conscious rats.
We were not able to examine the effect of higher doses of estradiol, because of the low solubility of this substance . But 30 mg/kg or 90 mg/kg of diethylstilbestrol diphosphate significantly reduced the blood pressure.
Since high concentrations of diethylstilbestrol decreased the basal pressure in the isolated mesenteric artery, the decrease in blood pressure we observed in vivo is likely to be attributable to the dilation of peripheral vessel. Estrogen has been reported to be a vasodilator substance in the peripheral vascular beds. Estrogen dilated the capillaries in the ear of the rabbit (Reynolds and Foster, 1940) and uterine vessels in man (Bore11 et al., 1953) , and decreased peripheral resistance in the sheep (Ueland and Parer, 1966) . But Lim et al., (1970) reported that an intravenous injection of 20 mg of estrone did not change the limb vascular resistance in man. These results seem to indicate that only huge amounts of estrogen can dilate the vessels. Clark et al., (1978) reported that vasodilation of rat uterine vessels induced by estradiol was prevented by pretreatment with a-adrenergic blocking agents, suggessting a specific interrelationship between catecholamines and estrogen. Krall et al., (1977) also reported that estrogen reduces the a-adrenergic receptor concentration in myometrium. Although the changes in blood pressure and vascular reactivity to norepinephrine are not always parallel (Doyle and Fraser, 1961 ; Ichikawa et al. 1978 ; Kondo et al. 1980) , our finding that vascular response to norepinephrine was attenuated by estrogen suggests that estrogen may reduce the sympathetic tone in vivo, and thereby dilates the peripheral vessels. However our preliminary experiments (unpublished data) showed that estradiol attenuated the vascular response of rat mesenteric artery to angiotensin II, potassium chloride or vasopressin.
Further studies on the vascular effects of estrogen are necessary to elucidate the mechanism of its action.
The chronic administration of estrogen increased the blood pressure in man (Laragh et al., 1967 ; Saruta et al., 1970) \ and in rats (Saruta et al., 1975) , and accelerated the development of hypertension with renovascular or DOCA-salt hypertension in rats (Bunag, 1976) . These changes in the cardiovascular system may be due to stimulation of the renin-angiotensin system or the sodium and water retention induced by estrogen 1975) . In contrast to these findings, estrogen treatment attenuated the development of hypertension in spontaneous hypertensive rats (Hoeg et al., 1977) and inhibited DOCA-salt hypertension in chickens (Stamler, 1954) . The inhibitory effect of estrogen on the development of hypertension could possibly be explained by the direct effect of estrogen on the vascular beds such as observed in our present study. It should thus be stressed. that the direct effect of estrogen, as well as the chronic changes in the hormonal and sodium balance induced by estrogen, should be considered when the effect of estrogen on blood pressure is discussed.
Diethylstilbestrol diphosphate is a commonly used estrogen which is usually administered intravenously.
This substance was reported to have slight estrogen-like activity before it is hydrolyzed by phosphatase in the tissue (Druckrey and Raabe, 1952) . In the present experiments the inhibitory effect of estradiol on the vascular response to norepinephrine was 10-50 times higher than that of diethylstilbestrol diphosphate. But the doses of diethylstilbestrol diphosphate we used in this experiment were comparable to those in clinical use (Band et al., 1973 ; Smith, 1975 
